Arrowhead Pharmaceuticals, Inc.

SEI INVESTMENTS CO ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

112,279

Value ($000)

7,454

Weight

0.0%

2019 Q4 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	7,454	0.0%	112,279	12/31/2025
2025 Q3	11/13/2025	470	0.0%	13,616	9/30/2025
2025 Q2	8/14/2025	212	0.0%	13,422	6/30/2025
2025 Q1	5/14/2025	165	0.0%	12,962	3/31/2025
2024 Q2	8/13/2024	258	0.0%	9,908	6/30/2024
2024 Q1	5/7/2024	308	0.0%	10,774	3/31/2024
2023 Q4	2/14/2024	338	0.0%	11,054	12/31/2023
2023 Q3	11/14/2023	301	0.0%	11,194	9/30/2023
2023 Q2	8/11/2023	575	0.0%	16,121	6/30/2023
2022 Q4	2/10/2023	464	0.0%	11,447	12/31/2022
2022 Q3	11/14/2022	391	0.0%	11,820	9/30/2022
2022 Q2	8/15/2022	331	0.0%	9,390	6/30/2022
2022 Q1	5/13/2022	438	0.0%	9,534	3/31/2022
2021 Q4	2/14/2022	881	0.0%	13,291	12/31/2021
2021 Q3	11/12/2021	847	0.0%	13,561	9/30/2021
2021 Q2	8/6/2021	1,142	0.0%	13,790	6/30/2021
2021 Q1	5/12/2021	2,001	0.0%	27,984	3/31/2021
2020 Q4	2/8/2021	2,196	0.0%	28,619	12/31/2020
2020 Q3	12/4/2020	650	0.0%	15,104	9/30/2020
2020 Q2	8/17/2020	464	0.0%	10,734	6/30/2020
2019 Q4	2/6/2020	1,151	0.0%	18,150	12/31/2019